IndyGeneUS Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 10

IndyGeneUS Bio General Information

Description

Operator of a gene-targeted therapeutics company focused on developing a multi-omic data analysis and management therapy. The company is engaged in creating the blockchain-encrypted repository of indigenous and diasporic African clinical and multi-omics data for disease prevention and detection, drug discovery and development, clinical disease management, and precision health equity data, enabling professionals to deliver treatments to patients more efficiently.

Contact Information

Website
indygeneus.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 North Martin Luther King Junior Boulevard
  • Baltimore, MD
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 4 North Martin Luther King Junior Boulevard
  • Baltimore, MD
  • United States
+1 (650)

IndyGeneUS Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IndyGeneUS Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 01-Jan-2024 $1.8M Completed Generating Revenue
7. Accelerator/Incubator 06-Sep-2023 Completed Generating Revenue
6. Accelerator/Incubator 20-Dec-2022 Completed Generating Revenue
5. Accelerator/Incubator 14-Oct-2022 Completed Generating Revenue
4. Grant 12-May-2022 Completed Generating Revenue
3. Seed Round 15-Nov-2021 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2020 Completed Startup
To view IndyGeneUS Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

IndyGeneUS Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IndyGeneUS Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Google Accelerator Accelerator/Incubator Minority
Merck Digital Sciences Studio Accelerator/Incubator
Endless Frontier Labs Accelerator/Incubator
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
IsimoVest Venture Capital Partners PE/Buyout Minority
You’re viewing 5 of 10 investors. Get the full list »

IndyGeneUS Bio Acquisitions (2)

IndyGeneUS Bio’s most recent deal was a Merger/Acquisition with BrainRap. The deal was made on 25-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BrainRap 25-Mar-2024 Merger/Acquisition Media and Information Services (B2B)
Encrypgen 24-Nov-2021 Merger/Acquisition Business/Productivity Software
To view IndyGeneUS Bio’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

IndyGeneUS Bio FAQs

  • When was IndyGeneUS Bio founded?

    IndyGeneUS Bio was founded in 2020.

  • Where is IndyGeneUS Bio headquartered?

    IndyGeneUS Bio is headquartered in Baltimore, MD.

  • What is the size of IndyGeneUS Bio?

    IndyGeneUS Bio has 5 total employees.

  • What industry is IndyGeneUS Bio in?

    IndyGeneUS Bio’s primary industry is Discovery Tools (Healthcare).

  • Is IndyGeneUS Bio a private or public company?

    IndyGeneUS Bio is a Private company.

  • What is IndyGeneUS Bio’s current revenue?

    The current revenue for IndyGeneUS Bio is .

  • How much funding has IndyGeneUS Bio raised over time?

    IndyGeneUS Bio has raised $3.8M.

  • Who are IndyGeneUS Bio’s investors?

    Google Accelerator, Merck Digital Sciences Studio, Endless Frontier Labs, Johnson & Johnson Innovation - JLABS, and IsimoVest Venture Capital Partners are 5 of 10 investors who have invested in IndyGeneUS Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process